Ritonavir and COVID-19: pragmatic guidance is important

Lancet. 2022 Apr 16;399(10334):1464-1465. doi: 10.1016/S0140-6736(22)00280-X. Epub 2022 Mar 22.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use
  • COVID-19 Drug Treatment*
  • Drug Combinations
  • Humans
  • Lopinavir / therapeutic use
  • Ritonavir* / therapeutic use

Substances

  • Antiviral Agents
  • Drug Combinations
  • Lopinavir
  • Ritonavir